Democratic Republic of the Congo & United States — Food and Drug Administration
4 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Accidents
Democratic Republic of the Congo: The Democratic Republic of the Congo>>> is the epicenter of the current Ebola outbreak, with hundreds of suspected cases and deaths, facing significant challenges in containment due to conflict, weak health infrastructure, and public mistrust.
United States — Food and Drug Administration: The United States — Food and Drug Administration has approved Inmazeb, a combination of antibodies, to treat Zaire Ebolavirus infection, which Regeneron Pharmaceuticals has donated for potential use in the current outbreak.
May 18, 2026 · 505 articles
International
Democratic Republic of the Congo: The Democratic Republic of the Congo is experiencing a severe Ebola outbreak with over 100 deaths, complicated by conflict and challenges in response efforts.
United States — Food and Drug Administration: The United States — Food and Drug Administration is the regulatory body that Revolution Medicines will seek approval from for its experimental pancreatic cancer drug, daraxonrasib.
May 18, 2026 · 243 articles
NEWSDESK
Explore this relationship live
Track how Democratic Republic of the Congo and United States — Food and Drug Administration interact across events, view sentiment trends, and discover connected entities.
Open Dashboard